You are here: Home » PTI Stories » National » News
Business Standard

Strides Shasun shares rise over 5% on USFDA approval for new drug

Press Trust of India  |  New Delhi 

Shares of today rose by over 5 per cent after the company's subsidiary received final approval from the US health regulator for generic Phosphate capsules.

The stock gained 3.83 per cent to close at Rs 363.05 on BSE. During the day, it jumped 5.53 per cent to Rs 369.

At NSE, shares of the company rose by 5.28 per cent to end at Rs 368.30.

In terms of equity volume, 12.39 lakh shares of the firm were traded on BSE and over one crore shares changed hands at NSE during the day.

Pte has received approval from the (USFDA) for the capsules in the strengths of 30 mg (base), 45 mg (base) and 75 mg (base), said in a BSE filing yesterday.

The product is a generic version of Hoffmann-La Roche Inc's Tamiflu capsules, it added.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, June 12 2018. 16:30 IST